Characterization of Post-COVID Syndrome by Self-Perceived Symptom Severity Stratified by Infection Wave: Beyond COVID, A Prospective, Multicenter Cohort Study in Germany

May 2026 in “ Infection ”

Alexander Mertens, Judith Smith, Ingmar Bergs, Julia Fischer, S. Jansen, Sven Breitschwerdt, Elisabeth Pracht, Alexander Killer, Lukas Schipper, Nils Kuklik, Mirjam Frank, Julia Schwichtenberg, Siona Bührmann, Lina Zeissler, Michael Dreher, Jürgen Rockstroh, Hana Rohn, Clara Lehmann, Phil-Robin Tepasse, Börge Schmidt, Nico Dragano, J G Bode, Tom Luedde, Björn-Erik-Ole Jensen, for the Beyond COVID Study Group, Smaranda Gliga, Paul Park, Clara de Angelis, Charlotte Flaßhove, Lila Haberl, Alice Kang, J Veelken, Jonel Trebicka, Richard Vollenberg, Christoph Boesecke, Margarethe Konik, Oliver Witzke, Dominik Benke, Sarah Fünger, J J Malin, Sonja Knez, Yasemin Sovic, Julia Wolf

Studysummary This study found that a significant portion of the Beyond-COVID cohort reported persistent symptoms, with Omicron variants showing lower rates and severity of symptoms compared to other variants.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Post-Acute COVID-19 Symptom Risk in Hospitalized and Non-Hospitalized COVID-19 Survivors: A Systematic Review and Meta-Analysis

34 citations , February 2023 in “Frontiers in Public Health”

This meta-analysis found that hospitalized COVID-19 survivors have a significantly higher risk of experiencing long-term symptoms like dyspnea, anxiety, myalgia, and hair loss compared to those not hospitalized.

research Relationship Between Hair Shedding and Systemic Inflammation in COVID-19 Pneumonia

3 citations , March 2022 in “Annals of Medicine”

This study suggests that telogen effluvium is more closely related to the severity of COVID-19 and associated inflammation than to hormonal factors, with women showing a higher prevalence.

research Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis

25 citations , February 2022 in “JAAD International”

This review analyzed data on alopecia types associated with COVID-19, suggesting androgenetic alopecia may be a risk factor for severe COVID-19, while telogen effluvium often follows infection and alopecia areata tends to relapse in those with preexisting disease.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , November 2020 in “Journal of the European Academy of Dermatology and Venereology”

This article discusses SARS-CoV-2-induced telogen effluvium in a multicentric study and reports no new clinical results.